Calcium-dependent networks in dopamine-glutamate interaction: The role of postsynaptic scaffolding proteins

Molecular Neurobiology

Volumn 46, Issue 2, 2012, Pages 275-296

  De Bartolomeis, Andrea ^a   Tomasetti, Carmine ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Antipsychotics; Homer; Postsynaptic density; PSD95; Psychosis; Shank

Indexed keywords

CALCIUM ION; CLOZAPINE; DOPAMINE; DOPAMINE RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POSTSYNAPTIC DENSITY PROTEIN 95; SCAFFOLD PROTEIN;

ARTICLE; CALCIUM SIGNALING; CELL NUCLEUS; CORPUS STRIATUM; GABAERGIC SYSTEM; HUMAN; MOLECULAR INTERACTION; NERVE CELL PLASTICITY; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PSYCHOSIS; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPSE;

EID: 84868117909     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-012-8293-6     Document Type: Article

References (237)

1. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG (1998) Dopamine receptors: from structure to function. Physiol Rev 78 (1):189-225 (Pubitemid 28070979)
2. Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62(3):405-496
3. Conn PJ, Pin JP (1997) Pharmacology and functions of metabotropic glutamate receptors. Annu Rev Pharmacol Toxicol 37:205-237 (Pubitemid 27238875)
4. Pin JP, Duvoisin R (1995) The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34(1):1-26
5. Nicoletti F, Bockaert J, Collingridge GL, Conn PJ, Ferraguti F, Schoepp DD, Wroblewski JT, Pin JP (2011) Metabotropic glutamate receptors: from the workbench to the bedside. Neuropharmacology 60(7-8):1017-1041
6. Paoletti P (2011) Molecular basis of NMDA receptor functional diversity. Eur J Neurosci 33(8):1351-1365
7. Yao WD, Spealman RD, Zhang J (2008) Dopaminergic signaling in dendritic spines. Biochem Pharmacol 75(11):2055-2069
8. Oliveira AM, Bading H (2011) Calcium signaling in cognition and aging-dependent cognitive decline. Biofactors 37(3):168-174
9. de Bartolomeis A, Iasevoli F (2003) The Homer family and the signal transduction system at glutamatergic postsynaptic density: potential role in behavior and pharmacotherapy. Psychopharmacol Bull 37(3):51-83
10. Simeone A, Di Salvio M, Di Giovannantonio LG, Acampora D, Omodei D, Tomasetti C (2011) The role of otx2 in adult mesencephalic-diencephalic dopaminergic neurons. Mol Neurobiol 43 (2):107-113
11. Simeone A, Puelles E,Omodei D, Acampora D, Di Giovannantonio LG, Di Salvio M, Mancuso P, Tomasetti C (2011) Otx genes in neurogenesis of mesencephalic dopaminergic neurons. Dev Neurobiol 71(8):665-679
12. Hoftman GD, Lewis DA (2011) Postnatal developmental trajectories of neural circuits in the primate prefrontal cortex: identifying sensitive periods for vulnerability to schizophrenia. Schizophr Bull 37(3):493-503
13. Hashimoto R, Tankou S, Takeda M, Sawa A (2007) Postsynaptic density: a key convergent site for schizophrenia susceptibility factors and possible target for drug development. Drugs Today (Barc) 43(9):645-654 (Pubitemid 350004869)
14. Rao JS, Kellom M, Reese EA, Rapoport SI, Kim HW (2012) Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients. J Affect Disord 136(1-2):63-71
15. Chen G, Henter ID, Manji HK (2010) Presynaptic glutamatergic dysfunction in bipolar disorder. Biol Psychiatry 67(11):1007-1009
16. Tepper JM, Abercrombie ED, Bolam JP (2007) Basal ganglia macrocircuits. Prog Brain Res 160:3-7 (Pubitemid 46702282)
17. Del Arco A, Mora F (2008) Prefrontal cortex-nucleus accumbens interaction: in vivo modulation by dopamine and glutamate in the prefrontal cortex. Pharmacol Biochem Behav 90(2):226-235
18. Cousins DA, Butts K, Young AH (2009) The role of dopamine in bipolar disorder. Bipolar Disord 11(8):787-806
19. Stone JM, Morrison PD, Pilowsky LS (2007) Glutamate and dopamine dysregulation in schizophrenia-a synthesis and selective review. J Psychopharmacol 21(4):440-452 (Pubitemid 47077295)
20. Zarate C Jr, Machado-Vieira R, Henter I, Ibrahim L, Diazgranados N, Salvadore G (2010) Glutamatergic modulators: the future of treating mood disorders? Harv Rev Psychiatry 18(5):293-303
21. Bondi C, Matthews M, Moghaddam B (2012) Glutamatergic animal models of schizophrenia. Curr Pharm Des 18:1593-1604
22. Schwartz TL, Sachdeva S, Stahl SM (2012) Genetic data supporting the NMDA glutamate receptor hypothesis for schizophrenia. Curr Pharm Des 18:1580-1592
23. Woo TU, Walsh JP, Benes FM (2004) Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 61(7):649-657 (Pubitemid 38890797)
24. Carr DB, Sesack SR (1996) Hippocampal afferents to the rat prefrontal cortex: synaptic targets and relation to dopamine terminals. J Comp Neurol 369(1):1-15 (Pubitemid 26137477)
25. Bergson C, Mrzljak L, Smiley JF, Pappy M, Levenson R, Goldman-Rakic PS (1995) Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain. J Neurosci 15(12):7821-7836 (Pubitemid 26006891)
26. de Almeida J, Mengod G (2010) D2 and D4 dopamine receptor mRNA distribution in pyramidal neurons and GABAergic subpopulations in monkey prefrontal cortex: implications for schizophrenia treatment. Neuroscience 170(4):1133-1139
27. Cepeda C, Andre VM, Jocoy EL, Levine MS (2009) NMDA and dopamine: diverse mechanisms applied to interacting receptor systems. In: Van Dongen AM (ed) Biology of the NMDA receptor. CRC Press, Boca Raton (FL), Chapter 3
28. Muly EC, Maddox M, Smith Y (2003) Distribution of mGluR1-alpha and mGluR5 immunolabeling in primate prefrontal cortex. J Comp Neurol 467(4):521-535 (Pubitemid 37467128)
29. Tamaru Y, Nomura S, Mizuno N, Shigemoto R (2001) Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites. Neuroscience 106(3):481-503 (Pubitemid 32925240)
30. Vinson PN, Conn PJ (2012) Metabotropic glutamate receptors as therapeutic targets for schizophrenia. Neuropharmacology 62 (3):1461-1472
31. Muly EC 3rd, Szigeti K, Goldman-Rakic PS (1998) D1 receptor in interneurons of macaque prefrontal cortex: distribution and subcellular localization. J Neurosci 18(24):10553-10565 (Pubitemid 29016574)
32. Smith Y, Villalba R (2008) Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains. Mov Disord 23(Suppl 3):S534-S547
33. Tarazi FI, Baldessarini RJ (1999) Brain dopamine D(4) receptors: basic and clinical status. Int J Neuropsychopharmacol 2(1):41-58
34. Tarazi FI, Baldessarini RJ (1999) Regional localization of dopamine and ionotropic glutamate receptor subtypes in striatolimbic brain regions. J Neurosci Res 55(4):401-410 (Pubitemid 29110548)
35. Tarazi FI, Campbell A, Yeghiayan SK, Baldessarini RJ (1998) Localization of dopamine receptor subtypes in corpus striatum and nucleus accumbens septi of rat brain: comparison of D1-, D2-, and D4-like receptors. Neuroscience 83(1):169-176 (Pubitemid 28068047)
36. Tarazi FI, Yeghiayan SK, Neumeyer JL, Baldessarini RJ (1998) Medial prefrontal cortical D2 and striatolimbic D4 dopamine receptors: common targets for typical and atypical antipsychotic drugs. Prog Neuropsychopharmacol Biol Psychiatry 22(4):693-707 (Pubitemid 28281231)
37. Paquet M, Smith Y (2003) Group I metabotropic glutamate receptors in the monkey striatum: subsynaptic association with glutamatergic and dopaminergic afferents. J Neurosci 23 (20):7659-7669 (Pubitemid 37034083)
38. David HN, Ansseau M, Abraini JH (2005) Dopamine-glutamate reciprocal modulation of release and motor responses in the rat caudate-putamen and nucleus accumbens of "intact" animals. Brain Res Brain Res Rev 50(2):336-360 (Pubitemid 41654400)
39. Del Arco A, Mora F (2009) Neurotransmitters and prefrontal cortex-limbic system interactions: implications for plasticity and psychiatric disorders. J Neural Transm 116(8):941-952
40. Wickens JR (2009) Synaptic plasticity in the basal ganglia. Behav Brain Res 199(1):119-128
41. Beaulieu JM, Gainetdinov RR (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63(1):182-217
42. Morgado-Bernal I (2011) Learning and memory consolidation: linking molecular and behavioral data. Neuroscience 176:12-19
43. Calabresi P, Picconi B, Tozzi A, Di Filippo M (2007) Dopamine-mediated regulation of corticostriatal synaptic plasticity. Trends Neurosci 30(5):211-219 (Pubitemid 46654232)
44. Shiflett MW, Balleine BW (2011) Molecular substrates of action control in cortico-striatal circuits. Prog Neurobiol 95(1):1-13
45. Okabe S (2007) Molecular anatomy of the postsynaptic density. Mol Cell Neurosci 34(4):503-518 (Pubitemid 46483087)
46. Sheng M, Hoogenraad CC (2007) The postsynaptic architecture of excitatory synapses: a more quantitative view. Annu Rev Biochem 76:823-847
47. Foa L, Gasperini R (2009) Developmental roles for Homer: more than just a pretty scaffold. J Neurochem 108(1):1-10
48. Zheng CY, Seabold GK, Horak M, Petralia RS (2011) MAGUKs, synaptic development, and synaptic plasticity. Neuroscientist 17 (5):493-512
49. Romero G, von Zastrow M, Friedman PA (2011) Role of PDZ proteins in regulating trafficking, signaling, and function of GPCRs: means, motif, and opportunity. Adv Pharmacol 62:279-314
50. Ciruela F, Canela L, Burgueno J, Soriguera A, Cabello N, Canela EI, Casado V, Cortes A, Mallol J, Woods AS, Ferre S, Lluis C, Franco R (2005) Heptaspanning membrane receptors and cytoskeletal/scaffolding proteins: focus on adenosine, dopamine, and metabotropic glutamate receptor function. J Mol Neurosci 26 (2-3):277-292 (Pubitemid 41389420)
51. de Bartolomeis A, Fiore G (2004) Postsynaptic density scaffolding proteins at excitatory synapse and disorders of synaptic plasticity: implications for human behavior pathologies. Int Rev Neurobiol 59:221-254 (Pubitemid 39752417)
52. de Bartolomeis A, Fiore G, Iasevoli F (2005) Dopamine-glutamate interaction and antipsychotics mechanism of action: implication for new pharmacological strategies in psychosis. Curr Pharm Des 11 (27):3561-3594 (Pubitemid 41300760)
53. Szumlinski KK, Dehoff MH, Kang SH, Frys KA, Lominac KD, Klugmann M, Rohrer J, Griffin W 3rd, Toda S, Champtiaux NP, Berry T, Tu JC, Shealy SE, During MJ, Middaugh LD, Worley PF, Kalivas PW (2004) Homer proteins regulate sensitivity to cocaine. Neuron 43(3):401-413 (Pubitemid 39061131)
54. Szumlinski KK, Lominac KD, Kleschen MJ, Oleson EB, Dehoff MH, Schwarz MK, Seeburg PH, Worley PF, Kalivas PW (2005) Behavioral and neurochemical phenotyping of Homer1 mutant mice: possible relevance to schizophrenia. Genes Brain Behav 4 (5):273-288 (Pubitemid 41002403)
55. Wyneken U, Marengo JJ, Orrego F (2004) Electrophysiology and plasticity in isolated postsynaptic densities. Brain Res Brain Res Rev 47(1-3):54-70 (Pubitemid 39574311)
56. Brakeman PR, Lanahan AA, O'Brien R, Roche K, Barnes CA, Huganir RL, Worley PF (1997) Homer: a protein that selectively binds metabotropic glutamate receptors. Nature 386(6622):284-288 (Pubitemid 27142514)
57. Kato A, Ozawa F, Saitoh Y, Fukazawa Y, Sugiyama H, Inokuchi K (1998) Novel members of the Vesl/Homer family of PDZ proteins that bind metabotropic glutamate receptors. J Biol Chem 273(37):23969-23975 (Pubitemid 28435736)
58. Xiao B, Tu JC, Petralia RS, Yuan JP, Doan A, Breder CD, Ruggiero A, Lanahan AA, Wenthold RJ, Worley PF (1998) Homer regulates the association of group 1 metabotropic glutamate receptors with multivalent complexes of homer-related, synaptic proteins. Neuron 21(4):707-716 (Pubitemid 28498780)
59. Sun J, Tadokoro S, Imanaka T, Murakami SD, Nakamura M, Kashiwada K, Ko J, Nishida W, Sobue K (1998) Isolation of PSD-Zip45, a novel Homer/vesl family protein containing leucine zipper motifs, from rat brain. FEBS Lett 437(3):304-308 (Pubitemid 28511180)
60. de Bartolomeis A, Aloj L, Ambesi-Impiombato A, Bravi D, Caraco C, Muscettola G, Barone P (2002) Acute administration of antipsychotics modulates Homer striatal gene expression differentially. Brain Res Mol Brain Res 98(1-2):124-129 (Pubitemid 34142286)
61. Bottai D, Guzowski JF, Schwarz MK, Kang SH, Xiao B, Lanahan A, Worley PF, Seeburg PH (2002) Synaptic activity-induced conversion of intronic to exonic sequence in Homer 1 immediate early gene expression. J Neurosci 22(1):167-175 (Pubitemid 34033494)
62. Hennou S, Kato A, Schneider EM, Lundstrom K, Gahwiler BH, Inokuchi K, Gerber U, Ehrengruber MU (2003) Homer-1a/Vesl-1S enhances hippocampal synaptic transmission. Eur J Neurosci 18(4):811-819 (Pubitemid 37059691)
63. Sala C, Roussignol G, Meldolesi J, Fagni L (2005) Key role of the postsynaptic density scaffold proteins Shank and Homer in the functional architecture of Ca2+ homeostasis at dendritic spines in hippocampal neurons. J Neurosci 25(18):4587-4592 (Pubitemid 40629149)
64. Xiao B, Tu JC, Worley PF (2000) Homer: a link between neural activity and glutamate receptor function. Curr Opin Neurobiol 10 (3):370-374 (Pubitemid 30389305)
65. Hwang SY, Wei J, Westhoff JH, Duncan RS, Ozawa F, Volpe P, Inokuchi K, Koulen P (2003) Differential functional interaction of two Vesl/Homer protein isoforms with ryanodine receptor type 1: a novel mechanism for control of intracellular calcium signaling. Cell Calcium 34(2):177-184 (Pubitemid 36798401)
66. Kammermeier PJ, Xiao B, Tu JC, Worley PF, Ikeda SR (2000) Homer proteins regulate coupling of group I metabotropic glutamate receptors to N-type calcium and M-type potassium channels. J Neurosci 20(19):7238-7245
67. Tu JC, Xiao B, Naisbitt S, Yuan JP, Petralia RS, Brakeman P, Doan A, Aakalu VK, Lanahan AA, Sheng M, Worley PF (1999) Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins. Neuron 23(3):583-592 (Pubitemid 29359928)
68. Tu JC, Xiao B, Yuan JP, Lanahan AA, Leoffert K, Li M, Linden DJ, Worley PF (1998) Homer binds a novel proline-rich motif and links group 1 metabotropic glutamate receptors with IP3 receptors. Neuron 21(4):717-726 (Pubitemid 28498781)
69. Yuan JP, Kiselyov K, Shin DM, Chen J, Shcheynikov N, Kang SH, Dehoff MH, Schwarz MK, Seeburg PH, Muallem S, Worley PF (2003) Homer binds TRPC family channels and is required for gating of TRPC1 by IP3 receptors. Cell 114(6):777-789 (Pubitemid 37186771)
70. Abe H, Misaka T, Tateyama M, Kubo Y (2003) Effects of coexpression with Homer isoforms on the function of metabotropic glutamate receptor 1alpha. Mol Cell Neurosci 23(2):157-168 (Pubitemid 36703154)
71. Shiraishi Y, Mizutani A, Yuasa S, Mikoshiba K, Furuichi T (2003) Glutamate-induced declustering of post-synaptic adaptor protein Cupidin (Homer 2/vesl-2) in cultured cerebellar granule cells. J Neurochem 87(2):364-376 (Pubitemid 37255244)
72. Shiraishi Y, Mizutani A, Yuasa S, Mikoshiba K, Furuichi T (2004) Differential expression of Homer family proteins in the developing mouse brain. J Comp Neurol 473(4):582-599 (Pubitemid 38580452)
73. French PJ, O'Connor V, Jones MW, Davis S, Errington ML, Voss K, Truchet B, Wotjak C, Stean T, Doyere V, Maroun M, Laroche S, Bliss TV (2001) Subfield-specific immediate early gene expression associated with hippocampal long-term potentiation in vivo. Eur J Neurosci 13(5):968-976 (Pubitemid 32226148)
74. Polese D, de Serpis AA, Ambesi-Impiombato A, Muscettola G, de Bartolomeis A (2002) Homer 1a gene expression modulation by antipsychotic drugs: involvement of the glutamate metabotropic system and effects of D-cycloserine. Neuropsychopharmacology 27(6):906-913 (Pubitemid 35447627)
75. Worley PF, Zeng W, Huang G, Kim JY, Shin DM, Kim MS, Yuan JP, Kiselyov K, Muallem S (2007) Homer proteins in Ca2+ signaling by excitable and non-excitable cells. Cell Calcium 42 (4-5):363-371 (Pubitemid 47264010)
76. Bertaso F, Roussignol G, Worley P, Bockaert J, Fagni L, Ango F (2010) Homer1a-dependent crosstalk between NMDA and metabotropic glutamate receptors in mouse neurons. PLoS One 5(3):e9755
77. Huang G, Kim JY, Dehoff M, Mizuno Y, Kamm KE, Worley PF, Muallem S, Zeng W (2007) Ca2+ signaling in microdomains: Homer1 mediates the interaction between RyR2 and Cav1.2 to regulate excitation-contraction coupling. J Biol Chem 282 (19):14283-14290 (Pubitemid 47100458)
78. Pouliquin P, Dulhunty AF (2009) Homer and the ryanodine receptor. Eur Biophys J 39(1):91-102
79. Duncan RS, Hwang SY, Koulen P (2005) Effects of Vesl/Homer proteins on intracellular signaling. Exp Biol Med (Maywood) 230 (8):527-535 (Pubitemid 41233151)
80. Yang L, Mao L, Tang Q, Samdani S, Liu Z, Wang JQ (2004) A novel Ca2+-independent signaling pathway to extracellular signal-regulated protein kinase by coactivation of NMDA receptors and metabotropic glutamate receptor 5 in neurons. J Neurosci 24(48):10846-10857 (Pubitemid 39602396)
81. Romorini S, Piccoli G, Jiang M, Grossano P, Tonna N, Passafaro M, Zhang M, Sala C (2004) A functional role of postsynaptic density-95-guanylate kinase-associated protein complex in regulating Shank assembly and stability to synapses. J Neurosci 24 (42):9391-9404 (Pubitemid 39429502)
82. Xu W (2011) PSD-95-like membrane associated guanylate kinases (PSD-MAGUKs) and synaptic plasticity. Curr Opin Neurobiol 21(2):306-312
83. Sturgill JF, Steiner P, Czervionke BL, Sabatini BL (2009) Distinct domains within PSD-95 mediate synaptic incorporation, stabilization, and activity-dependent trafficking. J Neurosci 29 (41):12845-12854
84. Migaud M, Charlesworth P, Dempster M, Webster LC, Watabe AM, Makhinson M, He Y, Ramsay MF, Morris RG, Morrison JH, O'Dell TJ, Grant SG (1998) Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature 396(6710):433-439 (Pubitemid 28553306)
85. Schnell E, Sizemore M, Karimzadegan S, Chen L, Bredt DS, Nicoll RA (2002) Direct interactions between PSD-95 and stargazin control synaptic AMPA receptor number. Proc Natl Acad Sci U S A 99(21):13902-13907 (Pubitemid 35215478)
86. Colledge M, Dean RA, Scott GK, Langeberg LK, Huganir RL, Scott JD (2000) Targeting of PKA to glutamate receptors through a MAGUK-AKAP complex. Neuron 27(1):107-119
87. El-Husseini Ael D, Schnell E, Dakoji S, Sweeney N, Zhou Q, Prange O, Gauthier-Campbell C, Aguilera-Moreno A, Nicoll RA, Bredt DS (2002) Synaptic strength regulated by palmitate cycling on PSD-95. Cell 108(6):849-863 (Pubitemid 34327535)
88. Xu J, Liu ZA, Pei DS, Xu TJ (2010) Calcium/calmodulin-dependent kinase II facilitated GluR6 subunit serine phosphorylation through GluR6-PSD95-CaMKII signaling module assembly in cerebral ischemia injury. Brain Res 1366:197-203
89. Ivenshitz M, Segal M (2010) Neuronal density determines network connectivity and spontaneous activity in cultured hippocampus. J Neurophysiol 104(2):1052-1060
90. Nassirpour R, Bahima L, Lalive AL, Luscher C, Lujan R, Slesinger PA (2010) Morphine- and CaMKII-dependent enhancement of GIRK channel signaling in hippocampal neurons. J Neurosci 30 (40):13419-13430
91. Boeckers TM, Bockmann J, Kreutz MR, Gundelfinger ED (2002) ProSAP/Shank proteins-a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease. J Neurochem 81(5):903-910 (Pubitemid 34809273)
92. Sala C, Piech V, Wilson NR, Passafaro M, Liu G, Sheng M (2001) Regulation of dendritic spine morphology and synaptic function by Shank and Homer. Neuron 31(1):115-130 (Pubitemid 32757093)
93. Boeckers TM (2006) The postsynaptic density. Cell Tissue Res 326(2):409-422 (Pubitemid 44435817)
94. Baron MK, Boeckers TM, Vaida B, Faham S, Gingery M, Sawaya MR, Salyer D, Gundelfinger ED, Bowie JU (2006) An architectural framework that may lie at the core of the postsynaptic density. Science 311(5760):531-535
95. Cepeda C, Levine MS (2006) Where do you think you are going? The NMDA-D1 receptor trap. Sci STKE 2006 333:pe20
96. Castner SA, Williams GV (2007) Tuning the engine of cognition: a focus on NMDA/D1 receptor interactions in prefrontal cortex. Brain Cogn 63(2):94-122
97. Chase TN, Oh JD (2000) Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism. Trends Neurosci 23(10 Suppl):S86-S91
98. Kreipke CW, Walker PD (2004) NMDA receptor blockade attenuates locomotion elicited by intrastriatal dopamine D1-receptor stimulation. Synapse 53(1):28-35 (Pubitemid 38703002)
99. Ferretti V, Florian C, Costantini VJ, Roullet P, Rinaldi A, De Leonibus E, Oliverio A, Mele A (2005) Co-activation of glutamate and dopamine receptors within the nucleus accumbens is required for spatial memory consolidation in mice. Psychopharmacol (Berl) 179(1):108-116 (Pubitemid 40576697)
100. Baldwin AE, Sadeghian K, Kelley AE (2002) Appetitive instrumental learning requires coincident activation of NMDA and dopamine D1 receptors within the medial prefrontal cortex. J Neurosci 22(3):1063-1071 (Pubitemid 34141786)
101. Cepeda C, Buchwald NA, Levine MS (1993) Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated. Proc Natl Acad Sci U S A 90(20):9576-9580 (Pubitemid 23315828)
102. Cepeda C, Colwell CS, Itri JN, Chandler SH, Levine MS (1998) Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: contribution of calcium conductances. J Neurophysiol 79(1):82-94 (Pubitemid 28133801)
103. Gulledge AT, Jaffe DB (2001) Multiple effects of dopamine on layer V pyramidal cell excitability in rat prefrontal cortex. J Neurophysiol 86(2):586-595 (Pubitemid 32738551)
104. Blank T, Nijholt I, Teichert U, Kugler H, Behrsing H, Fienberg A, Greengard P, Spiess J (1997) The phosphoprotein DARPP-32 mediates cAMP-dependent potentiation of striatal N-methyl-Daspartate responses. Proc Natl Acad Sci U S A 94(26):14859-14864 (Pubitemid 28041465)
105. Snyder GL, Fienberg AA, Huganir RL, Greengard P (1998) A dopamine/D1 receptor/protein kinase A/dopamine- and cAMPregulated phosphoprotein (Mr 32kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor. J Neurosci 18(24):10297-10303 (Pubitemid 29016549)
106. Tseng KY, O'Donnell P (2004) Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. J Neurosci 24(22):5131-5139 (Pubitemid 38728985)
107. Lee FJ, Xue S, Pei L, Vukusic B, Chery N, Wang Y, Wang YT, Niznik HB, Yu XM, Liu F (2002) Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell 111(2):219-230 (Pubitemid 35292442)
108. Scott L, Kruse MS, Forssberg H, Brismar H, Greengard P, Aperia A (2002) Selective up-regulation of dopamine D1 receptors in dendritic spines by NMDA receptor activation. Proc Natl Acad Sci U S A 99(3):1661-1664 (Pubitemid 34136549)
109. Dunah AW, Sirianni AC, Fienberg AA, Bastia E, Schwarzschild MA, Standaert DG (2004) Dopamine D1-dependent trafficking of striatal N-methyl-D-aspartate glutamate receptors requires Fyn protein tyrosine kinase but not DARPP-32. Mol Pharmacol 65 (1):121-129 (Pubitemid 38113892)
110. Goldman-Rakic PS (1995) Cellular basis of working memory. Neuron 14(3):477-485
111. Kotecha SA, Oak JN, Jackson MF, Perez Y, Orser BA, Van Tol HH, MacDonald JF (2002) A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission. Neuron 35(6):1111-1122 (Pubitemid 35279538)
112. Gulledge AT, Jaffe DB (1998) Dopamine decreases the excitability of layer V pyramidal cells in the rat prefrontal cortex. J Neurosci 18(21):9139-9151 (Pubitemid 28491775)
113. Hernandez-Echeagaray E, Starling AJ, Cepeda C, Levine MS (2004) Modulation of AMPA currents by D2 dopamine receptors in striatal medium-sized spiny neurons: are dendrites necessary? Eur J Neurosci 19(9):2455-2463 (Pubitemid 38621843)
114. Hakansson K, Galdi S, Hendrick J, Snyder G, Greengard P, Fisone G (2006) Regulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors. J Neurochem 96 (2):482-488
115. Yan Z, Feng J, Fienberg AA, Greengard P (1999) D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons. Proc Natl Acad Sci U S A 96(20):11607-11612 (Pubitemid 29487428)
116. Hernandez-Lopez S, Tkatch T, Perez-Garci E, Galarraga E, Bargas J, Hamm H, Surmeier DJ (2000) D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2+ currents and excitability via a novel PLC[beta]1-IP3- calcineurin-signaling cascade. J Neurosci 20(24):8987-8995 (Pubitemid 32042899)
117. Lei S, Lu WY, Xiong ZG, Orser BA, Valenzuela CF, MacDonald JF (1999) Platelet-derived growth factor receptor-induced feed-forward inhibition of excitatory transmission between hippocampal pyramidal neurons. J Biol Chem 274(43):30617-30623
118. Kim E, Sheng M (2004) PDZ domain proteins of synapses. Nat Rev Neurosci 5(10):771-781 (Pubitemid 39336214)
119. Zhang J, Vinuela A, Neely MH, Hallett PJ, Grant SG, Miller GM, Isacson O, Caron MG, Yao WD (2007) Inhibition of the dopamine D1 receptor signaling by PSD-95. J Biol Chem 282 (21):15778-15789 (Pubitemid 47093305)
120. Gu WH, Yang S, Shi WX, Jin GZ, Zhen XC (2007) Requirement of PSD-95 for dopamine D1 receptor modulating glutamate NR1a/NR2B receptor function. Acta Pharmacol Sin 28(6):756-762 (Pubitemid 46817432)
121. Zhang J, Xu TX, Hallett PJ, Watanabe M, Grant SG, Isacson O, Yao WD (2009) PSD-95 uncouples dopamine-glutamate interaction in the D1/PSD-95/NMDA receptor complex. J Neurosci 29 (9):2948-2960
122. Azdad K, Gall D, Woods AS, Ledent C, Ferre S, Schiffmann SN (2009) Dopamine D2 and adenosine A2A receptors regulate NMDA-mediated excitation in accumbens neurons through A2A-D2 receptor heteromerization. Neuropsychopharmacology 34(4):972-986
123. Svenningsson P, Le Moine C, Fisone G, Fredholm BB (1999) Distribution, biochemistry and function of striatal adenosine A2A receptors. Prog Neurobiol 59(4):355-396 (Pubitemid 29352341)
124. Stromberg I, Popoli P, Muller CE, Ferre S, Fuxe K (2000) Electrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A2A receptors in dopamine D2 receptor regulation in the rat dopamine-denervated striatum. Eur J Neurosci 12(11):4033-4037
125. Ciruela F, Burgueno J, Casado V, CanalsM,Marcellino D, Goldberg SR, Bader M, Fuxe K, Agnati LF, Lluis C, Franco R, Ferre S,Woods AS (2004) Combining mass spectrometry and pull-down techniques for the study of receptor heteromerization. Direct epitope-epitope electrostatic interactions between adenosine A2A and dopamine D2 receptors. Anal Chem 76(18):5354-5363 (Pubitemid 39249416)
126. Sheng M (2001) The postsynaptic NMDA-receptor-PSD-95 signaling complex in excitatory synapses of the brain. J Cell Sci 114 (Pt 7):1251 (Pubitemid 32409461)
127. Olson PA, Tkatch T, Hernandez-Lopez S, Ulrich S, Ilijic E, Mugnaini E, Zhang H, Bezprozvanny I, Surmeier DJ (2005) G-protein-coupled receptor modulation of striatal CaV1.3L-type Ca2+ channels is dependent on a Shankbinding domain. J Neurosci 25(5):1050-1062 (Pubitemid 40268947)
128. Alexander GM, Godwin DW (2006) Metabotropic glutamate receptors as a strategic target for the treatment of epilepsy. Epilepsy Res 71(1):1-22 (Pubitemid 44233196)
129. Otani S, Auclair N, Desce JM, Roisin MP, Crepel F (1999) Dopamine receptors and groups I and II mGluRs cooperate for long-term depression induction in rat prefrontal cortex through converging postsynaptic activation of MAP kinases. J Neurosci 19(22):9788-9802 (Pubitemid 30226652)
130. Bustos G, Abarca J, Campusano J, Bustos V, Noriega V, Aliaga E (2004) Functional interactions between somatodendritic dopamine release, glutamate receptors and brain-derived neurotrophic factor expression in mesencephalic structures of the brain. Brain Res Brain Res Rev 47(1-3):126-144 (Pubitemid 39574316)
131. Hu G, Duffy P, Swanson C, Ghasemzadeh MB, Kalivas PW (1999) The regulation of dopamine transmission by metabotropic glutamate receptors. J Pharmacol Exp Ther 289(1):412-416 (Pubitemid 29156057)
132. Katayama J, Akaike N, Nabekura J (2003) Characterization of pre- and post-synaptic metabotropic glutamate receptor-mediated inhibitory responses in substantia nigra dopamine neurons. Neurosci Res 45(1):101-115 (Pubitemid 36044474)
133. Wittmann M, Marino MJ, Conn PJ (2002) Dopamine modulates the function of group II and group III metabotropic glutamate receptors in the substantia nigra pars reticulata. J Pharmacol Exp Ther 302(2):433-441 (Pubitemid 34787205)
134. Schotanus SM, Chergui K (2008) Dopamine D1 receptors and group I metabotropic glutamate receptors contribute to the induction of long-term potentiation in the nucleus accumbens. Neuropharmacology 54(5):837-844
135. Kim JH, Austin JD, Tanabe L, Creekmore E, Vezina P (2005) Activation of group II mGlu receptors blocks the enhanced drug taking induced by previous exposure to amphetamine. Eur J Neurosci 21(1):295-300 (Pubitemid 40193900)
136. Kim WY, Vezina P, Kim JH (2008) Blockade of group II, but not group I, mGluRs in the rat nucleus accumbens inhibits the expression of conditioned hyperactivity in an amphetamine-associated environment. Behav Brain Res 191(1):62-66
137. Yoon HS, Jang JK, Kim JH (2008) Blockade of group II metabotropic glutamate receptors produces hyper-locomotion in cocaine pre-exposed rats by interactions with dopamine receptors. Neuropharmacology 55(4):555-559
138. Morishima Y, Miyakawa T, Furuyashiki T, Tanaka Y, Mizuma H, Nakanishi S (2005) Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice. Proc Natl Acad Sci U S A 102 (11):4170-4175] (Pubitemid 40388574)
139. David HN, Abraini JH (2003) Blockade of the locomotor stimulant effects of amphetamine by group I, group II, and group III metabotropic glutamate receptor ligands in the rat nucleus accumbens: possible interactions with dopamine receptors. Neuropharmacology 44(6):717-727 (Pubitemid 36385137)
140. Pietraszek M, Rogoz Z,Wolfarth S, Ossowska K (2004) Opposite influence of MPEP, an mGluR5 antagonist, on the locomotor hyperactivity induced by PCP and amphetamine. J Physiol Pharmacol 55(3):587-593 (Pubitemid 39318850)
141. Agnati LF, Ferre S, Lluis C, Franco R, Fuxe K (2003) Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol Rev 55(3):509-550 (Pubitemid 37013214)
142. Zoli M, Agnati LF, Hedlund PB, Li XM, Ferre S, Fuxe K (1993) Receptor-receptor interactions as an integrative mechanism in nerve cells. Mol Neurobiol 7(3-4):293-334
143. Fuxe K, Borroto-Escuela DO, Marcellino D, Romero-Fernandez W, Frankowska M, Guidolin D, Filip M, Ferraro L, Woods AS, Tarakanov A, Ciruela F, Agnati LF, Tanganelli S (2012) GPCR heteromers and their allosteric receptor-receptor interactions. Curr Med Chem 19(3):356-363
144. Fuxe K, Marcellino D, Rivera A, Diaz-Cabiale Z, Filip M, Gago B, Roberts DC, Langel U, Genedani S, Ferraro L, de la Calle A, Narvaez J, Tanganelli S, Woods A, Agnati LF (2008) Receptor-receptor interactions within receptor
145. Diaz-Cabiale Z, Vivo M, Del Arco A, O'Connor WT, Harte MK, Muller CE, Martinez E, Popoli P, Fuxe K, Ferre S (2002) Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors. Neurosci Lett 324(2):154-158 (Pubitemid 34457827)
146. Popoli P, Pezzola A, Torvinen M, Reggio R, Pintor A, Scarchilli L, Fuxe K, Ferre S (2001) The selective mGlu(5) receptor agonist CHPG inhibits quinpirole-induced turning in 6-hydroxydopamine-lesioned rats and modulates the binding characteristics of dopamine D(2) receptors in the rat striatum: interactions with adenosine A(2a) receptors. Neuropsychopharmacology 25(4):505-513 (Pubitemid 32830955)
147. Fuxe K, Agnati LF, Jacobsen K, Hillion J, Canals M, Torvinen M, Tinner-Staines B, Staines W, Rosin D, Terasmaa A, Popoli P, Leo G, Vergoni V, Lluis C, Ciruela F, Franco R, Ferre S (2003) Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson's disease. Neurology 61(11 Suppl 6):S19-S23 (Pubitemid 37505541)
148. Nishi A, Liu F, Matsuyama S, Hamada M, Higashi H, Nairn AC, Greengard P (2003) Metabotropic mGlu5 receptors regulate adenosine A2A receptor signaling. Proc Natl Acad Sci U S A 100(3):1322-1327 (Pubitemid 36184000)
149. Cabello N, Gandia J, Bertarelli DC, Watanabe M, Lluis C, Franco R, Ferre S, Lujan R, Ciruela F (2009) Metabotropic glutamate type 5, dopamine D2 and adenosine A2a receptors form higher-order oligomers in living cells. J Neurochem 109(5):1497-1507
150. Higley MJ, Sabatini BL (2010) Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors. Nat Neurosci 13(8):958-966
151. Ferre S, Karcz-Kubicha M, Hope BT, Popoli P, Burgueno J, Gutierrez MA, Casado V, Fuxe K, Goldberg SR, Lluis C, Franco R, Ciruela F (2002) Synergistic interaction between adenosine A2A and glutamate mGlu5 receptors: implications for striatal neuronal function. Proc Natl Acad Sci U S A 99(18):11940-11945 (Pubitemid 34994503)
152. Wirkner K, Assmann H, Koles L, Gerevich Z, Franke H, Norenberg W, Boehm R, Illes P (2000) Inhibition by adenosine A(2A) receptors of NMDA but not AMPA currents in rat neostriatal neurons. Br J Pharmacol 130(2):259-269 (Pubitemid 30261035)
153. Kreitzer AC, Malenka RC (2008) Striatal plasticity and basal ganglia circuit function. Neuron 60(4):543-554
154. Anwyl R (2009) Metabotropic glutamate receptor-dependent long-term potentiation. Neuropharmacology 56(4):735-740
155. Bonsi P, Pisani A, Bernardi G, Calabresi P (2003) Stimulus frequency, calcium levels and striatal synaptic plasticity. Neuro-Report 14(3):419-422 (Pubitemid 36337942)
156. Gubellini P, Saulle E, Centonze D, Bonsi P, Pisani A, Bernardi G, Conquet F, Calabresi P (2001) Selective involvement of mGlu1 receptors in corticostriatal LTD. Neuropharmacology 40(7):839-846 (Pubitemid 32510797)
157. Kerr JN, Wickens JR (2001) Dopamine D-1/D-5 receptor activation is required for long-term potentiation in the rat neostriatum in vitro. J Neurophysiol 85(1):117-124 (Pubitemid 32062122)
158. Pawlak V, Kerr JN (2008) Dopamine receptor activation is required for corticostriatal spike-timing-dependent plasticity. J Neurosci 28(10):2435-2446 (Pubitemid 351348182)
159. Shen W, Flajolet M, Greengard P, Surmeier DJ (2008) Dichotomous dopaminergic control of striatal synaptic plasticity. Science 321(5890):848-851
160. Anggono V, Huganir RL (2012) Regulation of AMPA receptor trafficking and synaptic plasticity. Curr Opin Neurobiol [Epub ahead of print]
161. Adermark L, Lovinger DM (2007) Combined activation of L-type Ca2+ channels and synaptic transmission is sufficient to induce striatal long-term depression. J Neurosci 27 (25):6781-6787 (Pubitemid 46983430)
162. Fremeau RT Jr, Burman J,Qureshi T, Tran CH, Proctor J, Johnson J, Zhang H, Sulzer D, Copenhagen DR, Storm-Mathisen J, Reimer RJ, Chaudhry FA, Edwards RH (2002) The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc Natl Acad Sci U S A 99(22):14488-14493 (Pubitemid 35257698)
163. Rayport S (2001) Glutamate is a cotransmitter in ventral midbrain dopamine neurons. Parkinsonism Relat Disord 7(3):261-264 (Pubitemid 32372510)
164. Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM (1996) The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci 16(2):436-447 (Pubitemid 26028804)
165. Cepeda C, Hurst RS, Altemus KL, Flores-Hernandez J, Calvert CR, Jokel ES, Grandy DK, Low MJ, Rubinstein M, Ariano MA, Levine MS (2001) Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice. J Neurophysiol 85(2):659-670 (Pubitemid 32147768)
166. Tang K, Low MJ, Grandy DK, Lovinger DM (2001) Dopamine-dependent synaptic plasticity in striatum during in vivo development. Proc Natl Acad Sci U S A 98(3):1255-1260 (Pubitemid 32121219)
167. Zhang H, Sulzer D (2003) Glutamate spillover in the striatum depresses dopaminergic transmission by activating group I metabotropic glutamate receptors. J Neurosci 23(33):10585-10592 (Pubitemid 37485272)
168. Mao L, Wang JQ (2002) Activation of metabotropic glutamate receptor mediates upregulation of transcription factor mRNA expression in rat striatum induced by acute administration of amphetamine. Brain Res 924(2):167-175 (Pubitemid 34103014)
169. Ango F, Robbe D, Tu JC, Xiao B, Worley PF, Pin JP, Bockaert J, Fagni L (2002) Homer-dependent cell surface expression of metabotropic glutamate receptor type 5 in neurons. Mol Cell Neurosci 20(2):323-329 (Pubitemid 34762140)
170. Kammermeier PJ (2006) Surface clustering of metabotropic glutamate receptor 1 induced by long Homer proteins. BMC Neurosci 7:1
171. Kammermeier PJ (2008) Endogenous homer proteins regulate metabotropic glutamate receptor signaling in neurons. J Neurosci 28(34):8560-8567
172. Mao L, Yang L, Tang Q, Samdani S, Zhang G, Wang JQ (2005) The scaffold protein Homer1b/c links metabotropic glutamate receptor 5 to extracellular signal-regulated protein kinase cascades in neurons. J Neurosci 25(10):2741-2752 (Pubitemid 40365185)
173. Ronesi JA, Huber KM (2008) Homer interactions are necessary for metabotropic glutamate receptor-induced long-term depression and translational activation. J Neurosci 28(2):543-547
174. Hu JH, Park JM, Park S, Xiao B, Dehoff MH, Kim S, Hayashi T, Schwarz MK, Huganir RL, Seeburg PH, Linden DJ, Worley PF (2010) Homeostatic scaling requires group I mGluR activation mediated by Homer1a. Neuron 68(6):1128-1142
175. Menard C, Quirion R (2012) Successful cognitive aging in rats: a role for mGluR5 glutamate receptors, homer 1 proteins and downstream signaling pathways. PLoS One 7(1):e28666
176. Ronesi JA, Collins KA, Hays SA, Tsai NP, Guo W, Birnbaum SG, Hu JH, Worley PF, Gibson JR, Huber KM (2012) Disrupted Homer scaffolds mediate abnormal mGluR5 function in a mouse model of fragile X syndrome. Nat Neurosci 15(3):431-440
177. Swanson CJ, Baker DA, Carson D, Worley PF, Kalivas PW (2001) Repeated cocaine administration attenuates group I metabotropic glutamate receptor-mediated glutamate release and behavioral activation: a potential role for Homer. J Neurosci 21 (22):9043-9052 (Pubitemid 33054866)
178. Ghasemzadeh MB, Vasudevan P, Mueller C, Seubert C, Mantsch JR (2009) Neuroadaptations in the cellular and postsynaptic group 1 metabotropic glutamate receptor mGluR5 and Homer proteins following extinction of cocaine self-administration. Neurosci Lett 452(2):167-171
179. Ary AW, Szumlinski KK (2007) Regional differences in the effects of withdrawal from repeated cocaine upon Homer and glutamate receptor expression: a two-species comparison. Brain Res 1184:295-305 (Pubitemid 350160565)
180. Szumlinski KK, Ary AW, Lominac KD, Klugmann M, Kippin TE (2008) Accumbens Homer2 overexpression facilitates alcohol-induced neuroplasticity in C57BL/6J mice. Neuropsychopharmacology 33(6):1365-1378 (Pubitemid 351521705)
181. Okvist A, Fagergren P, Whittard J, Garcia-Osta A, Drakenberg K, Horvath MC, Schmidt CJ, Keller E, Bannon MJ, Hurd YL (2011) Dysregulated postsynaptic density and endocytic zone in the amygdala of human heroin and cocaine abusers. Biol Psychiatry 69(3):245-252
182. Kuwajima M, Dehoff MH, Furuichi T, Worley PF, Hall RA, Smith Y (2007) Localization and expression of group I metabotropic glutamate receptors in the mouse striatum, globus pallidus, and subthalamic nucleus: regulatory effects of MPTP treatment and constitutive Homer deletion. J Neurosci 27(23):6249-6260 (Pubitemid 46890016)
183. Choe ES, Chung KT, Mao L, Wang JQ (2002) Amphetamine increases phosphorylation of extracellular signal-regulated kinase and transcription factors in the rat striatum via group I metabotropic glutamate receptors. Neuropsychopharmacology 27 (4):565-575
184. Parelkar NK, Wang JQ (2004) mGluR5-dependent increases in immediate early gene expression in the rat striatum following acute administration of amphetamine. Brain Res Mol Brain Res 122(2):151-157 (Pubitemid 38317073)
185. Voulalas PJ, Holtzclaw L, Wolstenholme J, Russell JT, Hyman SE (2005) Metabotropic glutamate receptors and dopamine receptors cooperate to enhance extracellular signal-regulated kinase phosphorylation in striatal neurons. J Neurosci 25 (15):3763-3773 (Pubitemid 40570409)
186. Yano M, Steiner H (2005) Methylphenidate (Ritalin) induces Homer 1a and zif 268 expression in specific corticostriatal circuits. Neuroscience 132(3):855-865
187. Zhang GC, Mao LM, Liu XY, Parelkar NK, Arora A, Yang L, Hains M, Fibuch EE, Wang JQ (2007) In vivo regulation of Homer1a expression in the striatum by cocaine. Mol Pharmacol 71(4):1148-1158 (Pubitemid 46457018)
188. Yamada H, Kuroki T, Nakahara T, Hashimoto K, Tsutsumi T, Hirano M, Maeda H (2007) The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens. Brain Res 1131(1):88-96 (Pubitemid 46053909)
189. Distelhorst CW, Bootman MD (2011) Bcl-2 interaction with the inositol 1,4,5-trisphosphate receptor: role in Ca(2+) signaling and disease. Cell Calcium 50(3):234-241
190. Lidow MS (2003) Calcium signaling dysfunction in schizophrenia: a unifying approach. Brain Res Brain Res Rev 43 (1):70-84 (Pubitemid 37130081)
191. Naisbitt S, Valtschanoff J, Allison DW, Sala C, Kim E, Craig AM, Weinberg RJ, Sheng M (2000) Interaction of the postsynaptic density-95/guanylate kinase domain-associated protein complex with a light chain of myosin-V and dynein. J Neurosci 20(12):4524-4534 (Pubitemid 30396618)
192. Oyagi A, Oida Y, Kakefuda K, Shimazawa M, Shioda N, Moriguchi S, Kitaichi K, Nanba D, Yamaguchi K, Furuta Y, Fukunaga K, Higashiyama S, Hara H (2009) Generation and characterization of conditional heparin-binding EGF-like growth factor knockout mice. PLoS One 4(10):e7461
193. Beneyto M, Meador-Woodruff JH (2008) Lamina-specific abnormalities of NMDA receptor-associated postsynaptic protein transcripts in the prefrontal cortex in schizophrenia and bipolar disorder. Neuropsychopharmacology 33(9):2175-2186 (Pubitemid 351992080)
194. Clinton SM, Meador-Woodruff JH (2004) Abnormalities of the NMDA receptor and associated intracellular molecules in the thalamus in Schizophrenia and bipolar disorder. Neuropsycho-pharmacology 29(7):1353-1362 (Pubitemid 38780658)
195. Kristiansen LV, Meador-Woodruff JH (2005) Abnormal striatal expression of transcripts encoding NMDA interacting PSD proteins in schizophrenia, bipolar disorder and major depression. Schizophr Res 78(1):87-93 (Pubitemid 41188327)
196. Toro C, Deakin JF (2005) NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder. Schizophr Res 80 (2-3):323-330 (Pubitemid 41713658)
197. Tsai SJ, Hong CJ, Cheng CY, Liao DL, Liou YJ (2007) Association study of polymorphisms in post-synaptic density protein 95 (PSD-95) with schizophrenia. J Neural Transm 114(4):423-426
198. Szumlinski KK, Ary AW, Lominac KD (2008) Homers regulate drug-induced neuroplasticity: implications for addiction. Biochem Pharmacol 75(1):112-133 (Pubitemid 350235395)
199. Norton N, Williams HJ, Williams NM, Spurlock G, Zammit S, Jones G, Jones S, Owen R, O'Donovan MC, Owen MJ (2003) Mutation screening of the Homer gene family and association analysis in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 120B(1):18-21 (Pubitemid 37059373)
200. Spellmann I, Rujescu D, Musil R, Mayr A, Giegling I, Genius J, Zill P, Dehning S, Opgen-Rhein M, Cerovecki A, Hartmann AM, Schafer M, Bondy B, Muller N, Moller HJ, Riedel M (2011) Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients. J Psychiatr Res 45(2):234-241
201. Gilks WP, Allott EH, Donohoe G, Cummings E, International Schizophrenia Consortium, Gill M, Corvin AP, Morris DW (2010) Replicated genetic evidence supports a role for HOMER2 in schizophrenia. Neurosci Lett 468(3):229-233
202. Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, Nygren G, Rastam M, Gillberg IC, Anckarsater H, Sponheim E, Goubran-Botros H, Delorme R, Chabane N, Mouren-Simeoni MC, de Mas P, Bieth E, Roge B, Heron D, Burglen L, Gillberg C, Leboyer M, Bourgeron T (2007) Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 39(1):25-27 (Pubitemid 46026497)
203. Moessner R, Marshall CR, Sutcliffe JS, Skaug J, Pinto D, Vincent J, Zwaigenbaum L, Fernandez B, Roberts W, Szatmari P, Scherer SW (2007) Contribution of SHANK3 mutations to autism spectrum disorder. Am J Hum Genet 81(6):1289-1297 (Pubitemid 350211458)
204. Berkel S, Marshall CR, Weiss B, Howe J, Roeth R, Moog U, Endris V, Roberts W, Szatmari P, Pinto D, Bonin M, Riess A, Engels H, Sprengel R, Scherer SW, Rappold GA (2010) Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet 42(6):489-491
205. Berkel S, Tang W, Trevino M, Vogt M, Obenhaus HA, Gass P, Scherer SW, Sprengel R, Schratt G, Rappold GA (2012) Inherited and de novo SHANK2 variants associated with autism spectrum disorder impair neuronal morphogenesis and physiology. Hum Mol Genet 21(2):344-357
206. Hamdan FF, Gauthier J, Araki Y, Lin DT, Yoshizawa Y, Higashi K, Park AR, Spiegelman D, Dobrzeniecka S, Piton A, Tomitori H, Daoud H, Massicotte C, Henrion E, Diallo O, Group SD, Shekarabi M, Marineau C, Shevell M, Maranda B, Mitchell G, Nadeau A, D'Anjou G, Vanasse M, Srour M, Lafreniere RG, Drapeau P, Lacaille JC, Kim E, Lee JR, Igarashi K, Huganir RL, Rouleau GA, Michaud JL (2011) Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. Am J Hum Genet 88 (3):306-316
207. Gong Y, Lippa CF, Zhu J, Lin Q, Rosso AL (2009) Disruption of glutamate receptors at Shank-postsynaptic platform in Alzheimer's disease. Brain Res 1292:191-198
208. Pham E, Crews L, Ubhi K, Hansen L, Adame A, Cartier A, Salmon D, Galasko D, Michael S, Savas JN, Yates JR, Glabe C, Masliah E (2010) Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins. FEBS J 277(14):3051-3067
209. Roselli F, Hutzler P, Wegerich Y, Livrea P, Almeida OF (2009) Disassembly of shank and homer synaptic clusters is driven by soluble beta-amyloid(1-40) through divergent NMDARdependent signalling pathways. PLoS One 4(6):e6011
210. Gauthier J, Champagne N, Lafreniere RG, Xiong L, Spiegelman D, Brustein E, Lapointe M, Peng H, Cote M, Noreau A, Hamdan FF, Addington AM, Rapoport JL, Delisi LE, Krebs MO, Joober R, Fathalli F, Mouaffak F, Haghighi AP, Neri C, Dube MP, Samuels ME, Marineau C, Stone EA, Awadalla P, Barker PA, Carbonetto S, Drapeau P, Rouleau GA, TeamSD (2010) De novomutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia. Proc Natl Acad Sci U S A 107 (17):7863-7868
211. Lennertz L, Wagner M, Wolwer W, Schuhmacher A, Frommann I, Berning J, Schulze-Rauschenbach S, Landsberg MW, Steinbrecher A, Alexander M, Franke PE, Pukrop R, Ruhrmann S, Bechdolf A, GaebelW, Klosterkotter J, Hafner H,MaierW,Mossner R (2011) A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis. Eur Arch Psychiatry Clin Neurosci 262:117-124
212. Bangash MA, Park JM, Melnikova T, Wang D, Jeon SK, Lee D, Syeda S, Kim J, Kouser M, Schwartz J, Cui Y, Zhao X, Speed HE, Kee SE, Tu JC, Hu JH, Petralia RS, Linden DJ, Powell CM, Savonenko A, Xiao B, Worley PF (2011) Enhanced polyubiquitination of Shank3 and NMDA receptor in a mouse model of autism. Cell 145(5):758-772
213. Clay HB, Sillivan S, Konradi C (2011) Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci 29(3):311-324
214. Lopez-Tellez JF, Lopez-Aranda MF, Navarro-Lobato I, Masmudi-Martin M, Montanez EM, Calvo EB, Khan ZU (2010) Prefrontal inositol triphosphate is molecular correlate of working memory in nonhuman primates. J Neurosci 30(8):3067-3071
215. Luo Z, Volkow ND, Heintz N, Pan Y, Du C (2011) Acute cocaine induces fast activation of D1 receptor and progressive deactivation of D2 receptor striatal neurons: in vivo optical microprobe [Ca2+]i imaging. J Neurosci 31(37):13180-13190
216. Ninan I, Jardemark KE, Wang RY (2003) Differential effects of atypical and typical antipsychotic drugs on Nmethyl-D-aspartate- and electrically evoked responses in the pyramidal cells of the rat medial prefrontal cortex. Synapse 48(2):66-79 (Pubitemid 36374000)
217. Ninan I, Wang RY (2003) Modulation of the ability of clozapine to facilitate NMDA- and electrically evoked responses in pyramidal cells of the rat medial prefrontal cortex by dopamine: pharmacological evidence. Eur J Neurosci 17(6):1306-1312 (Pubitemid 36459786)
218. Purkayastha S, Ford J, Kanjilal B, Diallo S, Del Rosario IJ, Neuwirth L, El Idrissi A, Ahmed Z, Wieraszko A, Azmitia EC, Banerjee P (2012) Clozapine functions through the prefrontal cortex serotonin 1A receptor to heighten neuronal activity via calmodulin kinase II-NMDA receptor interactions. J Neurochem 120(3):396-407
219. Kargieman L, Riga MS, Artigas F, Celada P (2012) Clozapine reverses phencyclidine-induced desynchronization of prefrontal cortex through a 5-HT(1A) receptor-dependent mechanism. Neuropsychopharmacology 37(3):723-733
220. Yuen EY, Li X, Wei J, Horiguchi M, Meltzer HY, Yan Z (2012) The novel antipsychotic drug lurasidone enhances N-Methyl-Daspartate receptor-mediated synaptic responses. Mol Pharmacol 81(2):113-119
221. Jardemark K, Marcus MM, Shahid M, Svensson TH (2010) Effects of asenapine on prefrontal N-methyl-D-aspartate receptor-mediated transmission: involvement of dopamine D1 receptors. Synapse 64(11):870-874
222. Konradi C, Heckers S (2003) Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacol Ther 97(2):153-179 (Pubitemid 36138820)
223. Iasevoli F, Ambesi-Impiombato A, Fiore G, Panariello F, Muscettola G, de Bartolomeis A (2011) Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first- and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes. J Psychopharmacol 25(7):875-887
224. Iasevoli F, Fiore G, Cicale M, Muscettola G, de Bartolomeis A (2010) Haloperidol induces higher Homer1a expression than risperidone, olanzapine and sulpiride in striatal sub-regions. Psychiatry Res 177(1-2):255-260
225. Abbas AI, Yadav PN, Yao WD, Arbuckle MI, Grant SG, Caron MG, Roth BL (2009) PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptors. J Neurosci 29(22):7124-7136
226. Tomasetti C, Dell'Aversano C, Iasevoli F, de Bartolomeis A (2007) Homer splice variants modulation within corticosubcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action. Neuroscience 150(1):144-158 (Pubitemid 350198687)
227. Iasevoli F, Tomasetti C, Ambesi-Impiombato A, Muscettola G, de Bartolomeis A (2009) Dopamine receptor subtypes contribution to Homer1a induction: insights into antipsychotic molecular action. Prog Neuropsychopharmacol Biol Psychiatry 33(5):813-821
228. de Bartolomeis A, Tomasetti C, Cicale M, Yuan PX, Manji HK (2012) Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor. Eur Neuropsychopharmacol 22:527-535
229. Tomasetti C, Dell'Aversano C, Iasevoli F, Marmo F, de Bartolomeis A (2011) The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes. Prog Neuropsychopharmacol Biol Psychiatry 35(1):184-197
230. Dell'aversano C, Tomasetti C, Iasevoli F, de Bartolomeis A (2009) Antipsychotic and antidepressant co-treatment: effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders. Brain Res Bull 79(2):123-129
231. Critchlow HM, Maycox PR, Skepper JN, Krylova O (2006) Clozapine and haloperidol differentially regulate dendritic spine formation and synaptogenesis in rat hippocampal neurons. Mol Cell Neurosci 32(4):356-365 (Pubitemid 44163231)
232. Mueller HT, Haroutunian V, Davis KL, Meador-Woodruff JH (2004) Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia. Brain Res Mol Brain Res 121 (1-2):60-69 (Pubitemid 38224170)
233. Kristiansen LV, Beneyto M, Haroutunian V, Meador-Woodruff JH (2006) hanges in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia. Mol Psychiatry 8(11):737-747, 705 (Pubitemid 44141806)
234. Funk AJ, McCullumsmith RE, Haroutunian V, Meador-Woodruff JH (2012) Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia. Neuropsychopharmacology 37 (4):896-905
235. Lominac KD, Oleson EB, Pava M, Klugmann M, Schwarz MK, Seeburg PH, During MJ,Worley PF, Kalivas PW, Szumlinski KK (2005) Distinct roles for different Homer1 isoforms in behaviors and associated prefrontal cortex function. J Neurosci 25 (50):11586-11594 (Pubitemid 43098451)
236. Wang X, McCoy PA, Rodriguiz RM, Pan Y, Je HS, Roberts AC, Kim CJ, Berrios J, Colvin JS, Bousquet-Moore D, Lorenzo I, Wu G, Weinberg RJ, Ehlers MD, Philpot BD, Beaudet AL, Wetsel WC, Jiang YH (2011) Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum Mol Genet 20(15):3093-3108
237. Wohr M, Roullet FI, Hung AY, Sheng M, Crawley JN (2011) Communication impairments in mice lacking Shank1: reduced levels of ultrasonic vocalizations and scent marking behavior. PLoS One 6(6):e20631